Gilder Gagnon Howe & CO LLC Glaukos Corp Transaction History

Gilder Gagnon Howe & CO LLC

  • $7.87 Billion
  • Q3 2024

A detailed history of Gilder Gagnon Howe & CO LLC transactions in Glaukos Corp stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 658,599 shares of GKOS stock, worth $99.4 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
658,599
Previous 633,938 3.89%
Holding current value
$99.4 Million
Previous $75 Million 14.36%
% of portfolio
1.09%
Previous 0.99%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$113.62 - $135.39 $2.8 Million - $3.34 Million
24,661 Added 3.89%
658,599 $85.8 Million
Q2 2024

Aug 14, 2024
BUY
$89.48 - $118.35 $20.6 Million - $27.3 Million
230,630 Added 57.18%
633,938 $75 Million
Q1 2024

May 15, 2024
BUY
$76.4 - $96.33 $24.1 Million - $30.4 Million
315,847 Added 361.13%
403,308 $38 Million
Q4 2023

Feb 14, 2024
BUY
$59.53 - $85.11 $1.06 Million - $1.51 Million
17,773 Added 25.5%
87,461 $6.95 Million
Q3 2023

Nov 14, 2023
SELL
$69.23 - $79.09 $39,184 - $44,764
-566 Reduced 0.81%
69,688 $5.24 Million
Q2 2023

Aug 14, 2023
BUY
$45.44 - $71.21 $256,145 - $401,410
5,637 Added 8.72%
70,254 $5 Million
Q1 2023

May 15, 2023
BUY
$43.88 - $52.48 $13,734 - $16,426
313 Added 0.49%
64,617 $3.24 Million
Q4 2022

Feb 14, 2023
BUY
$40.82 - $57.75 $2.62 Million - $3.71 Million
64,304 New
64,304 $2.81 Million
Q4 2021

Feb 14, 2022
SELL
$40.27 - $56.99 $29.7 Million - $42.1 Million
-738,293 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$47.43 - $84.23 $4.7 Million - $8.35 Million
-99,156 Reduced 11.84%
738,293 $35.6 Million
Q2 2021

Aug 16, 2021
SELL
$73.06 - $97.7 $506,305 - $677,061
-6,930 Reduced 0.82%
837,449 $71 Million
Q1 2021

May 17, 2021
SELL
$70.43 - $97.42 $2.35 Million - $3.25 Million
-33,344 Reduced 3.8%
844,379 $70.9 Million
Q4 2020

Feb 16, 2021
SELL
$48.9 - $75.26 $207,776 - $319,779
-4,249 Reduced 0.48%
877,723 $66.1 Million
Q3 2020

Nov 16, 2020
SELL
$37.23 - $50.97 $600,222 - $821,738
-16,122 Reduced 1.8%
881,972 $43.7 Million
Q2 2020

Aug 14, 2020
SELL
$28.78 - $46.83 $1.05 Million - $1.7 Million
-36,319 Reduced 3.89%
898,094 $34.5 Million
Q1 2020

May 15, 2020
SELL
$25.53 - $70.14 $12.4 Million - $34.1 Million
-485,867 Reduced 34.21%
934,413 $28.8 Million
Q4 2019

Feb 14, 2020
SELL
$54.18 - $65.64 $995,394 - $1.21 Million
-18,372 Reduced 1.28%
1,420,280 $77.4 Million
Q3 2019

Nov 14, 2019
SELL
$58.58 - $83.91 $193,724 - $277,490
-3,307 Reduced 0.23%
1,438,652 $89.9 Million
Q2 2019

Aug 13, 2019
BUY
$63.59 - $78.71 $12.5 Million - $15.4 Million
195,906 Added 15.72%
1,441,959 $109 Million
Q1 2019

May 17, 2019
SELL
$50.75 - $80.54 $902,538 - $1.43 Million
-17,784 Reduced 1.41%
1,246,053 $97.7 Million
Q4 2018

Feb 14, 2019
SELL
$52.18 - $67.93 $988,497 - $1.29 Million
-18,944 Reduced 1.48%
1,263,837 $71 Million
Q3 2018

Oct 30, 2018
SELL
$38.13 - $68.37 $462,173 - $828,712
-12,121 Reduced 0.94%
1,282,781 $83.3 Million
Q2 2018

Jul 31, 2018
SELL
$27.62 - $44.51 $402,948 - $649,356
-14,589 Reduced 1.11%
1,294,902 $52.6 Million
Q1 2018

Apr 30, 2018
SELL
$26.05 - $34.5 $1.25 Million - $1.66 Million
-48,156 Reduced 3.55%
1,309,491 $40.4 Million
Q4 2017

Jan 31, 2018
SELL
$24.5 - $36.01 $2.32 Million - $3.42 Million
-94,858 Reduced 6.53%
1,357,647 $34.8 Million
Q3 2017

Nov 06, 2017
BUY
$31.26 - $42.03 $45.4 Million - $61 Million
1,452,505
1,452,505 $47.9 Million

Others Institutions Holding GKOS

# of Institutions
341
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Gilder Gagnon Howe & CO LLC Portfolio

Follow Gilder Gagnon Howe & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email